Amgen (AMGN.US) Q3 revenue and profit beat expectations, and full-year guidance was raised.

Zhitong Finance APP has learned that Amgen (AMGN.US) released its Q3 2026 report after the U.S. market close on November 3: total revenue was $10.365 billion, up 8% year over year, above the market estimate of about $10.05 billion; non-GAAP earnings per share were $6.45, up 14% year over year, significantly above the estimate of $5.77; GAAP earnings per share were $7.08, up 19% year over year.